fda warning compounding semaglutide october 2025 is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Drugmakers battle pharmacies over compounded

Document your injection site in a notebook or phone reminder to ensure you rotate properly each week and never inject into areas of existing lumps or scar tissue

"Our rigorous, customer-first approach strips away the friction of traditional healthcare, putting the power of health ownership back where it belongs: with the consumer. Wegovy is the only FDA-approved GLP-1 obesity pill Novo is the only company to gain FDA approval for a GLP-1 weight loss pill

Ultimately, less oversight across the boardin terms of process and productmakes any compounded drug an inherently riskier choice than a commercial option reviewed by the FDA

Important: Wegovy is NOT FDA-approved for sleep apneathat approval went to Zepbound (tirzepatide) in December 2024

If you have specific metabolic concerns, discuss them with your provider in the context of those conditions rather than weight loss